In a previous series, QLQX inhibited apoptosis and cardiac remodeling by activating the Neuregulin-1/AKT signaling pathway and inhibiting the p53 pathway in rats with heart failure (Wang et al., 2015). Here, AKT1 is linked to heart failure.